Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Peter Norman. (2003) Merck & Co., Inc.: analysis of patenting 1998 – 2002. Expert Opinion on Therapeutic Patents 13:7, pages 1037-1044.
Read now
Read now
John C Kath. (2000) Patent focus: inhibitors of tumour cell growth. Expert Opinion on Therapeutic Patents 10:6, pages 803-818.
Read now
Read now
ScottR. Lefler & SethD. Rose. (1999) Synthesis of Enol Esters from Copper(I) Carboxylates Generated from Copper(I) Trifluoromethanesulfonate Benzene Complex. Synthetic Communications 29:21, pages 3805-3810.
Read now
Read now
Theresa M Williams. (1999) Inhibitors of protein prenylation 1999. Expert Opinion on Therapeutic Patents 9:9, pages 1263-1280.
Read now
Read now
Articles from other publishers (17)
Alaa Z. Omar, Sherine N. Khattab, Mahmoud F. Ibrahim, Samir K. El‐Sadany & Ezzat A. Hamed. (2023)
Cyclization of 2,4‐dinitronaphth‐1‐yl amino acids and their analogues to naphthimindazol‐
N
‐oxides: Kinetics and mechanism
. Journal of Physical Organic Chemistry.
Crossref
Crossref
Imad Hammoudan, Aziz Aboulmouhajir, Mohamed Dakir, Driss Riffi Temsamani, Mohamed Bakhouch, Doaa El Bazi & Samir Chtita. (2022) Mechanistic elucidation of Diels–Alder cycloaddition reactions between quinoflavonoid and substituted butadiene using LOL, ELF, QTAIM, and DFT studies. Structural Chemistry 34:3, pages 959-969.
Crossref
Crossref
Katja Kettler, Jacek Sakowski, Katrin Silber, Isabel Sattler, Gerhard Klebe & Martin Schlitzer. (2003) Non-thiol farnesyltransferase inhibitors: n -(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorganic & Medicinal Chemistry 11:7, pages 1521-1530.
Crossref
Crossref
Andreas Mitsch, Markus Böhm, Pia Wißner, Isabel Sattler & Martin Schlitzer. (2002) Non-Thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones. Bioorganic & Medicinal Chemistry 10:8, pages 2657-2662.
Crossref
Crossref
Martin Schlitzer, Markus Böhm & Isabel Sattler. (2002) Non-thiol farnesyltransferase inhibitors: structure–activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry 10:3, pages 615-620.
Crossref
Crossref
Jacek Sakowski, Isabel Sattler & Martin Schlitzer. (2002) Non-thiol Farnesyltransferase Inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic Acid Amides. Bioorganic & Medicinal Chemistry 10:2, pages 233-239.
Crossref
Crossref
Jackson B. Gibbs. 2001. Protein Lipidation. Protein Lipidation
81
103
.
Charles Z Ding, John T Hunt, Carol Ricca & Veeraswamy Manne. (2000) 3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters 10:3, pages 273-275.
Crossref
Crossref
Bridget T Hill, Dominique Perrin & Anna Kruczynski. (2000) Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited. Critical Reviews in Oncology/Hematology 33:1, pages 7-23.
Crossref
Crossref
Dominique Perrin & Bridget T. Hill. 2000. New Approaches to Drug Development. New Approaches to Drug Development
153
179
.
Christopher J. Dinsmore, Theresa M. Williams, Timothy J. O'Neill, Dongming Liu, Elaine Rands, J.Christopher Culberson, Robert B. Lobell, Kenneth S. Koblan, Nancy E. Kohl, Jackson B. Gibbs, Allen I. Oliff, Samuel L. Graham & George D. Hartman. (1999) Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters 9:23, pages 3301-3306.
Crossref
Crossref
Hidekazu Tanaka, Kazuyo Nishida, Kenji Sugita & Takayuki Yoshioka. (1999) Antitumor Efficacy of Hypothemycin, A New Ras-signaling Inhibitor. Japanese Journal of Cancer Research 90:10, pages 1139-1145.
Crossref
Crossref
Neville J. Anthony, Robert P. Gomez, Micheal D. Schaber, Scott D. Mosser, Kelly A. Hamilton, Timothy J. O'Neil, Kenneth S. Koblan, Samuel L. Graham, George D. Hartman, Daksha Shah, Elaine Rands, Nancy E. Kohl, Jackson B. Gibbs & Allen I. Oliff. (1999) Design and in Vivo Analysis of Potent Non-Thiol Inhibitors of Farnesyl Protein Transferase. Journal of Medicinal Chemistry 42:17, pages 3356-3368.
Crossref
Crossref
Celeste E. O'Connell, Karen Ackermann, Cheryl A. Rowell, Ana Maria Garcia, Michael D. Lewis & C.Eric Schwartz. (1999) Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters 9:14, pages 2095-2100.
Crossref
Crossref
Terrence M. Ciccarone, Suzanne C. MacTough, Theresa M. Williams, Christopher J. Dinsmore, Timothy J. O'Neill, Daksha Shah, J.Christopher Culberson, Kenneth S. Koblan, Nancy E. Kohl, Jackson B. Gibbs, Allen I. Oliff, Samuel L. Graham & George D. Hartman. (1999) Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters 9:14, pages 1991-1996.
Crossref
Crossref
David J. Augeri, Dave Janowick, Douglas Kalvin, Gerry Sullivan, John Larsen, Daniel Dickman, Hong Ding, Jerry Cohen, Jang Lee, Robert Warner, Peter Kovar, Sajeev Cherian, Badr Saeed, Haichao Zhang, Steve Tahir, Shi-Chung Ng, Hing Sham & Saul H. Rosenberg. (1999) Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase. Bioorganic & Medicinal Chemistry Letters 9:8, pages 1069-1074.
Crossref
Crossref
Wang Shen, Stephen Fakhoury, Greg Donner, Kenneth Henry, Jang Lee, Haichao Zhang, Jerry Cohen, Robert Warner, Badr Saeed, Sajeev Cherian, Stephen Tahir, Peter Kovar, Joy Bauch, Shi-Chung Ng, Kennan Marsh, Hing Sham & Saul Rosenberg. (1999) Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements. Bioorganic & Medicinal Chemistry Letters 9:5, pages 703-708.
Crossref
Crossref